FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure | Reuters
Links shared publicly online about this topic.
- 1,665total visits
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure | Reuters
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and Twynsta(R) as New Combination Treatment for High Blood Pressure MICARDIS is First ARB Indicated to Reduce Risk of Cardiovascular
View full resource at reuters.com
Tags: Heart Disease, High Blood Pressure, High Blood Pressure Medication, FDA, Micardis
Most Recently Shared on October 19, 2009 at 1:59 pm By:
FDA Approves New Use for Micardis(R) in Cardiovascular Risk Reduction and ... http://bit.ly/2yT1Qw
Advertisement
